speb/financial-data huggingface dataset:
VET.TO balance_sheet (quarterly, 2025-03-31) — Financial Assets: 4392000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 865986000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 48561000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 98265000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 13675000.00
VET.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -36073000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 208518000.00
VET.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 35666000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6425868000.00
VET.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 290320000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 40227000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 29889000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 105898000.00
VET.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 32979000.00
VET.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 32979000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 21409000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 48561000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4755321000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1255746000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 78536000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 78536000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1306809000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 56835000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1874033000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1930868000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1306809000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -403296000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1092293000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -1084456000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -16576000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 1850505000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 35899000.00
VET.TO income_statement (quarterly, 2025-03-31) — Net Income: 14953000.00
VET.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 14953000.00
VET.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 3849000.00
VET.TO income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 11104000.00
VET.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 14953000.00
VET.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3849000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 14953000.00
VET.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 14953000.00
VET.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -32979000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 903513000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 903513000.00
VET.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -32979000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2430000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 10829000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 6425868000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -182119000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2881288000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 65248000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 379342000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 65248000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 379342000.00
VET.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 258443000.00
VET.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 34511050.00
VET.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 280384000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 49574000.00
VET.TO income_statement (quarterly, 2025-03-31) — Operating Income: 96840000.00
VET.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 484968000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 154177000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 47826000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 208518000.00
VET.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 29735000.00
VET.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -50858000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 8852000.00
VET.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -14785000.00
VET.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 157814000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Payables: 670318000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 670318000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 76314000.00
VET.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 13003000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Properties: 373864000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -1084456000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
VET.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -182119000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 321096000.00
VET.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 194648000.00
VET.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 176388000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -403296000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -16576000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1278074000.00
VET.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 5931000.00
VET.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 35666000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 154177000.00
VET.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 5931000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2881288000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2881288000.00
VET.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -5410950.00
VET.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 9154000.00
VET.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
VET.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 15141000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 7083770000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4755321000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 1930868000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2881288000.00
VET.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 388128000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4202482000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 6574044000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3484338000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 105898000.00
VET.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -36073000.00
VET.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -36073000.00
VET.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: -208418000.00
VET.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 205249000.00
VET.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 472306000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 403525000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 279469000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 36351000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 372386000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 598435000.00
VET.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 154342000.00
VET.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -1.51
VET.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 23528000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -115489000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 52776000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3899500000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 69187000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 69187000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -20043000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 375000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 68812000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 104162000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -198989000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 140467000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -110825000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 45640000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 3899500000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2693625000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -6323000.00
VET.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 223501000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 1171777000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 603527000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -20997000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -20997000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 184167000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 80677000.00
VET.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 155778000.00
VET.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.51
VET.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -233458000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 20022000.00
VET.TO income_statement (quarterly, 2025-06-30) — EBIT: 165292000.00
VET.TO income_statement (quarterly, 2025-06-30) — EBITDA: 349459000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 19000.00
VET.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 69187000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Financial Assets: 15062000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 104162000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 62898000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 24978000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -59522000.00
VET.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 123783000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 279372000.00
VET.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 30915000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 5359511000.00
VET.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 248805000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 76558000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 92687000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 30042000.00
VET.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 37691000.00
VET.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 37691000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 51792000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 62898000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4644875000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -198989000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 77137000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 77137000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 333892000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 52776000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1951250000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2004026000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 333892000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -203488000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 940682000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -1591000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -6323000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 1882063000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -5450000.00
VET.TO income_statement (quarterly, 2025-06-30) — Net Income: -233458000.00
VET.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -233458000.00
VET.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 74385000.00
VET.TO income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -307843000.00
VET.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -233458000.00
VET.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 74385000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -233458000.00
VET.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -233458000.00
VET.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -37691000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 130404000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 130404000.00
VET.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -37691000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 124000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -81909000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 5359511000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -115489000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2693625000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 84653000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 385603000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 84653000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 385603000.00
VET.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 225676000.00
VET.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -30830550.00
VET.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 140467000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -64972000.00
VET.TO income_statement (quarterly, 2025-06-30) — Operating Income: 43556000.00
VET.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 472306000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 154018623.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 149938000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 279372000.00
VET.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 23937000.00
VET.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 121736000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 12880000.00
VET.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -2047000.00
VET.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 174334000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Payables: 453589000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 453589000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 65093000.00
VET.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 127601000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Properties: 322388000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -1591000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
VET.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -115489000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 299606000.00
VET.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 223501000.00
VET.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 184167000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -203488000.00
VET.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -6323000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1521598000.00
VET.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 6978000.00
VET.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 30915000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 154018623.00
VET.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1286000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2693625000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2693625000.00
VET.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 18567450.00
VET.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 53216000.00
VET.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
VET.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 20137000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 6708140000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 4644875000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 2004026000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2693625000.00
VET.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 428750000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4014515000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 5536363000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3410988000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 30042000.00
VET.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 123783000.00
VET.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 123783000.00
VET.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 568250000.00
VET.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 217210000.00
VET.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 464538000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 412669000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 188063000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 42289000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
VET.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 153731000.00
VET.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.02
VET.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 69187000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -146630000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -145562000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 50852000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3884570000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 46054000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 46054000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -20023000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 5241000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 40813000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -738403000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 325061000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 389453000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 148972000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -23889000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 3884570000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -20023000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2708243000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -6320000.00
VET.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 216467000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 394584000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 489424000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 24073000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 24073000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 174033000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 60951000.00
VET.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 154921000.00
VET.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.02
VET.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2557000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 19947000.00
VET.TO income_statement (quarterly, 2025-09-30) — EBIT: 56238000.00
VET.TO income_statement (quarterly, 2025-09-30) — EBITDA: 230271000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 756000.00
VET.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 46054000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Financial Assets: 14627000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -738403000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 45292000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 242823000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -16558000.00
VET.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 24915000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 311763000.00
VET.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 24964000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 5407407000.00
VET.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 248071000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 44544000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 49628000.00
VET.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 34408000.00
VET.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 34408000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 19832000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 45292000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3972586000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 325061000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 76492000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 76492000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 50852000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1264343000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1315195000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
VET.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -276463000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 985221000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -6320000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 1218289000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 41171000.00
VET.TO income_statement (quarterly, 2025-09-30) — Net Income: 2557000.00
VET.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2557000.00
VET.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -4774000.00
VET.TO income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 7331000.00
VET.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2557000.00
VET.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -4774000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2557000.00
VET.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2557000.00
VET.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -34408000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -711932000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -276463000.00
VET.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -34408000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -128000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -11834000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 5407407000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 482457000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -435469000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2708243000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 60427000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 394503000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 60427000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 394503000.00
VET.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 205356000.00
VET.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -25951750.00
VET.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 389453000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 24613000.00
VET.TO income_statement (quarterly, 2025-09-30) — Operating Income: 30861000.00
VET.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 464538000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 153434000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 7180000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 311763000.00
VET.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 19027000.00
VET.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 25377000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 9268000.00
VET.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 462000.00
VET.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 192246000.00
VET.TO income_statement (quarterly, 2025-09-30) — Other Taxes: -1663000000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Payables: 482244000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 482244000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 62226000.00
VET.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 21830000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Properties: 326067000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
VET.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1068000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 196468000.00
VET.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 216467000.00
VET.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 174033000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -711932000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -6320000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1530379000.00
VET.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 5937000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 483525000.00
VET.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 24964000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 153434000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -435469000.00
VET.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5937000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2708243000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2708243000.00
VET.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 3737250.00
VET.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 26604000.00
VET.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
VET.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 8405000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 5953537000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3972586000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 1315195000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2708243000.00
VET.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 433677000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3245294000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5558953000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2755870000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 49628000.00
VET.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 24915000.00
VET.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 24915000.00
VET.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: -94840000.00
VET.TO income_statement (annual, 2025-12-31) — +Operating Expense: 836649000.00
VET.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 220531000.00
VET.TO income_statement (annual, 2025-12-31) — +Total Revenue: 1884265000.00
VET.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 462453000.00
VET.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 470765000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 470765000.00
VET.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 261532000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 261532000.00
VET.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -9533604000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -9533604000.00
VET.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 46469000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 46469000.00
VET.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 944545000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 572159000.00
VET.TO balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 43885000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 43885000.00
VET.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 153863000.00
VET.TO income_statement (annual, 2025-12-31) — Basic EPS: -4.25
VET.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 131730000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 46054000.00
VET.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -634922000.00
VET.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 49340000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 49340000.00
VET.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 3871914000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 3871914000.00
VET.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 19087000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 19087000.00
VET.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 19087000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 19087000.00
VET.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -98428000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -39841000.00
VET.TO balance_sheet (annual, 2025-12-31) — Cash Equivalents: 0.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 0.00
VET.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 19087000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 19087000.00
VET.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 180902000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -50843000.00
VET.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1238736000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -109062000.00
VET.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 943661000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 133357000.00
VET.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -4104000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -75953000.00
VET.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -114173000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -26548000.00
VET.TO balance_sheet (annual, 2025-12-31) — Common Stock: 3871914000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 3871914000.00
VET.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2221861000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2221861000.00
VET.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -35746000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -6527000.00
VET.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 880099000.00
VET.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 245482000.00
VET.TO balance_sheet (annual, 2025-12-31) — Current Assets: 467286000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 467286000.00
VET.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 554547000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 554547000.00
VET.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -37581000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -31641000.00
VET.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -37581000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -31641000.00
VET.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 743387000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 208799000.00
VET.TO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 52872000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 52872000.00
VET.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 153863000.00
VET.TO income_statement (annual, 2025-12-31) — Diluted EPS: -4.25
VET.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -653601000.00
VET.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -437653000.00
VET.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 0.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 0.00
VET.TO income_statement (annual, 2025-12-31) — EBIT: -192067000.00
VET.TO income_statement (quarterly, 2025-12-31) — EBIT: -459401000.00
VET.TO income_statement (annual, 2025-12-31) — EBITDA: 551320000.00
VET.TO income_statement (quarterly, 2025-12-31) — EBITDA: -250602000.00
VET.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 1530000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -419000.00
VET.TO cash_flow (annual, 2025-12-31) — End Cash Position: 19087000.00
VET.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 19087000.00
VET.TO balance_sheet (annual, 2025-12-31) — Financial Assets: 25266000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Financial Assets: 25266000.00
VET.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 180902000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -50843000.00
VET.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 46621000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 46621000.00
VET.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 308739000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 1028720000.00
VET.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -116299000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -53894000.00
VET.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 218072000.00
VET.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 105445000.00
VET.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 283763000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 283763000.00
VET.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 123616000.00
VET.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 32018000.00
VET.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 14322385000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 14322385000.00
VET.TO income_statement (annual, 2025-12-31) — Gross Profit: 1004166000.00
VET.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 216971000.00
VET.TO balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 78694000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 78694000.00
VET.TO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 572159000.00
VET.TO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 125632000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 12866000.00
VET.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 23124000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 23124000.00
VET.TO income_statement (annual, 2025-12-31) — Interest Expense: 132748000.00
VET.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 27670000.00
VET.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 132748000.00
VET.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 27670000.00
VET.TO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 131232000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 38199000.00
VET.TO balance_sheet (annual, 2025-12-31) — Inventory: 46621000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 46621000.00
VET.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 3465258000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3465258000.00
VET.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1238736000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -109062000.00
VET.TO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 43885000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 43885000.00
VET.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 43885000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 43885000.00
VET.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1008360000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -196872000.00
VET.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 49340000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 49340000.00
VET.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 1243397000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1243397000.00
VET.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1292737000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1292737000.00
VET.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1008360000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
VET.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -916920000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -33673000.00
VET.TO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 905232000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 905232000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -605236000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -35746000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -6527000.00
VET.TO balance_sheet (annual, 2025-12-31) — Net Debt: 1224310000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 1224310000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 41406000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -30214000.00
VET.TO income_statement (annual, 2025-12-31) — Net Income: -653601000.00
VET.TO income_statement (quarterly, 2025-12-31) — Net Income: -437653000.00
VET.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -653601000.00
VET.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -437653000.00
VET.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -364805000.00
VET.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -438119000.00
VET.TO income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: -288796000.00
VET.TO income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 466000.00
VET.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -653601000.00
VET.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -437653000.00
VET.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -364805000.00
VET.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -438119000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -653601000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -437653000.00
VET.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -653601000.00
VET.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -437653000.00
VET.TO income_statement (annual, 2025-12-31) — Net Interest Income: -132748000.00
VET.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -27670000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 41782000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 41782000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 317342000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -4643000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 91440000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -33673000.00
VET.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -132748000.00
VET.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -27670000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2266000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 168000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -40360000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 42554000.00
VET.TO balance_sheet (annual, 2025-12-31) — Net PPE: 4788781000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 4788781000.00
VET.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -634922000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -31332000.00
VET.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 225902000.00
VET.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 29030000.00
VET.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2221861000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2221861000.00
VET.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 19002000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 19002000.00
VET.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 316971000.00
VET.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 316971000.00
VET.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 19002000.00